orthopedics-osteoporosis-2018-keynote

6 / 6

E u r o p e a n C o n f e r e n c e o n
Orthopedics and
Osteoporosis
Journal of Clinical & Experimental Orthopaedics
ISSN: 2471-8416
N o v e m b e r 2 9 - 3 0 , 2 0 1 8
Am s t e r d a m , N e t h e r l a n d s
Orthopedics and Osteoporosis 2018
Page 34
Metatarsus adductus (MA) is the most common deformity among infants,
which is not sufficiently studied, and treated despite the documented long-
term discomfort and pains. The MA's prevalence is estimated between 0.1-12%
(POSNA). Disadvantages and complications of serial casting technique, and
possible chance of spontaneous repair in some cases, lead to advice for treatment
only in severe cases of varus foot deformities (VDF), leaving themild andmoderate
cases behind for possibly self-healing. There is a wide consensus that early
treatment before the age of 10months is essential for successful results. Here, we
present our patented UNFO device, the strategy and protocol of UNFO therapy for
MA, consisting of diagnosis, classification, technical details of UNFO application
and follow-up. UNFO system is well tolerated and simply used by parents with
constant daily support by the UNFO orthotists in our organization that makes
this treatment as a comfortable and safe experience for them. UNFO system is
used for all kinds of varus foot deformities with different severity and rigidity.
UNFO is used 23 h/d for 2-8 weeks according to severity of the case, followed
by maintenance night time usage for more 6-8 weeks accordingly. Full correction
is observed during 2 weeks. Complete recovery is presented in all cases with
minor side effects. The UNFO medical center is a community institution with a
large number of babies referred to us from all over Israel. UNFO therapy is already
replacing the unnecessary serial casting for VFD in Israel and other countries
Biography
Izak Daizade has graduated from Medical School of Iran
National University in Teheran 1978. He moved to Israel in
1979 and completed his Residency in General Orthopedic
Surgery in 1989. During his Residency at Beilinson University
Hospital in Petah Tiqva, Israel, he had Fellowships in Vascular
Surgery, General Surgery, Microsurgery and Neurosurgery. He
has developed and patented unique foot orthotics in 2007 and
founded the UNFO Med Ltd in 2010 to continue developing
innovative treatments for newborns afflicted with congenital
foot deformities. His company produces UNFO devices
which are currently used in many countries as the protocol of
treatment in varus foot deformities. He is the Director of the
R&D department in UNFO Company. He conducts seminars
and workshops in many countries and his company promotes
the new concept of UNFO therapy.
UNFO therapy (universal neonatal foot
orthotics), innovative therapeutic
concept and strategy for treatment of
metatarsus adductus (MA) in newborns
Izak Daizade
UNFO Medical center, Israel
Izak Daizade, J Clin Exp Orthop 2018, Volume: 4
DOI: 10.4172/2471-8416-C1-004